Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E24.31 EPS (ttm)5.61 Insider Own0.07% Shs Outstand2.68B Perf Week3.01%
Market Cap365.93B Forward P/E15.00 EPS next Y9.09 Insider Trans-23.89% Shs Float2.68B Perf Month6.51%
Income15.30B PEG3.68 EPS next Q2.15 Inst Own68.80% Short Float0.52% Perf Quarter-5.74%
Sales81.58B P/S4.49 EPS this Y-12.20% Inst Trans0.18% Short Ratio1.39 Perf Half Y4.56%
Book/sh24.09 P/B5.66 EPS next Y5.71% ROA0.90% Target Price144.22 Perf Year5.17%
Cash/sh7.22 P/C18.90 EPS next 5Y6.61% ROE2.20% 52W Range118.62 - 148.99 Perf YTD5.68%
Dividend3.60 P/FCF39.28 EPS past 5Y6.20% ROI15.10% 52W High-8.46% Beta0.67
Dividend %2.64% Quick Ratio1.40 Sales past 5Y2.60% Gross Margin66.90% 52W Low14.97% ATR1.91
Employees134000 Current Ratio1.70 Sales Q/Q3.60% Oper. Margin21.80% RSI (14)66.09 Volatility1.24% 1.41%
OptionableYes Debt/Eq0.48 EPS Q/Q4.90% Profit Margin1.70% Rel Volume0.66 Prev Close134.31
ShortableYes LT Debt/Eq0.46 EarningsJan 22 BMO Payout572.60% Avg Volume10.06M Price136.38
Recom- SMA203.75% SMA502.98% SMA2002.98% Volume6,659,928 Change1.54%
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
Feb-15-19 10:28PM  Johnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives' CNBC Videos
07:34PM  Cramer Remix: This single statement by Nvidia speaks volumes CNBC
06:26PM  Johnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives' CNBC
04:08PM  Johnson & Johnson International Fin Svc Co -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson Moody's
02:00PM  The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings Benzinga
01:21PM  This Is One Company That Could Break Up Bristol-Celgene Deal Investor's Business Daily
Feb-14-19 05:54PM  Veracyte CEO navigated early troubles, now has her company on path to growth American City Business Journals
04:45PM  Bayer stresses drug's tolerability in bid for prostate cancer market Reuters
03:44PM  Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B Zacks
03:15PM  10 Hot Stocks Leading the Markets Blitz Higher InvestorPlace
01:43PM  Is Johnson & Johnson CEO Alex Gorsky Earning His Pay? InvestorPlace
12:03PM  FDA Panel Nod for J&J's Esketamine Is Good News for Allergan, Vistagen GuruFocus.com
10:31AM  Johnson & Johnson to Participate in the 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
08:15AM  Did Johnson & Johnson Just Spit in Alphabet's Face? Motley Fool
12:53AM  [$$] J&J and Novartis back cancer geneticists immunotherapy start-up Financial Times
Feb-13-19 07:28PM  [$$] Johnson & Johnson to Buy Surgical Robotics Maker The Wall Street Journal
06:40PM  Johnson & Johnson supplier seeks bankruptcy over talc lawsuits Reuters
05:53PM  Imerys Talc Units File Bankruptcy as Cancer-Suit Risk Soars Bloomberg
05:07PM  [$$] Johnson & Johnson Talc Supplier Files for Bankruptcy The Wall Street Journal
04:22PM  Johnson & Johnson supplier seeks bankruptcy over talc lawsuits Reuters
04:20PM  Here Is What's Surprising About J&J's Robotic Surgery Buyout Investor's Business Daily
04:06PM  Dow Ends Off Highs but Optimism Remains Over a U.S.-China Trade Deal TheStreet.com
03:18PM  The Funded: 9 Bay Area startups raising nearly $900M at midweek American City Business Journals
03:02PM  Dow Jones Today: J&J Buys Robotics Firm; Cisco Systems Falls Ahead Of Earnings Investor's Business Daily
02:36PM  [$$] Johnson & Johnson to Buy Surgical Robotics Maker Auris The Wall Street Journal
02:19PM  Imerys Talc America files for bankruptcy under weight of talc litigation Reuters
01:58PM  Traders boost the wrong stock for a second time after J&J takeover CNBC
01:09PM  Imerys Talc America to file for Chapter 11 bankruptcy - statement Reuters
01:00PM  Johnson & Johnson to Buy Robotic Surgery Company Auris Health for $3.4 Billion TheStreet.com
12:50PM  Why Geron Stock Briefly Spiked Today Motley Fool
12:28PM  Johnson & Johnson to buy surgical robotics firm Auris for $3.4 billion Reuters
10:42AM  Case of Mistaken Identity Sends Auris Medical Shares Soaring 30% Bloomberg
09:38AM  Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits Benzinga
09:24AM  Johnson & Johnson to buy private robotics firm Auris for $3.4 billion Reuters
09:17AM  Johnson & Johnson will acquire surgical robotics company Auris Health MarketWatch
09:06AM  Johnson & Johnson to buy Auris Health for $3.4 billion CNBC
09:00AM  Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc. PR Newswire
07:49AM  The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering Benzinga
12:51AM  PRESS DIGEST-New York Times business news - Feb 13 Reuters
Feb-12-19 10:25PM  [$$] Johnson & Johnson to buy robotics group Auris Health for $3.4bn Financial Times
04:35PM  J&J's nasal spray for depression wins FDA panel backing Reuters
02:48PM  U.S. FDA panel recommends approval of Johnson & Johnson's depression drug Reuters
01:17PM  [$$] SEC Allows Rejection of Mandatory Shareholder Arbitration The Wall Street Journal
12:00PM  ARWRs 2019 Goals Include Data From Several Studies, Initiation of Ph2 ARO-AAT Zacks Small Cap Research
08:04AM  The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares Benzinga
Feb-11-19 05:20PM  SEC's Clayton says agency right not to rule on Johnson & Johnson shareholder proposal concerning mandatory arbitration MarketWatch
04:00PM  FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect Benzinga
07:27AM  What Are Analysts Saying About Johnson & Johnsons (NYSE:JNJ) Growth? Simply Wall St.
Feb-10-19 05:37PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Feb-08-19 12:20PM  Here's Why Arrowhead Pharmaceuticals Gained as Much as 15.8% Today Motley Fool
10:14AM  Johnson & Johnson Rolls Out a New Trump Appeasement Policy Bloomberg
09:17AM  The Daily Biotech Pulse: Big Miss For Seattle Genetics; Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs Benzinga
08:19AM  Apple teams up with Johnson & Johnson to help prevent strokes Fox Business Videos
Feb-07-19 06:50PM  J&J becomes first drugmaker to add prices to television ads Reuters
06:40PM  J&J becomes first drugmaker to add prices to television ads Reuters
02:26PM  Johnson & Johnson will list drug prices in TV commercials Associated Press
05:50AM  Swiss Idorsia says 'stay tuned' for deals as it manages pipeline Reuters
02:56AM  Idorsia will take three to four years to reach profitability, CEO says CNBC Videos
Feb-06-19 05:52PM  At least four pharma CEOs to testify at Senate drug pricing hearing Reuters
01:50PM  Sightbox CEO on life after acquisition and growth under J&J American City Business Journals
12:16PM  Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying CNBC
09:44AM  Pfizer CEO Bourla plans to testify at Senate drug pricing hearing Reuters
06:08AM  Winners & Losers from Trump's State of the Union Address Zacks
Feb-05-19 04:36PM  Johnson & Johnson to Participate in the 2019 CAGNY Conference PR Newswire
04:06PM  Merck CEO Frazier to testify at Senate drug pricing hearing Reuters
12:00PM  The Late Morning Rundown: February 05, 2019 CNBC Videos
11:38AM  Pharma execs will testify before Congress 'one way or another,' US senator says CNBC
08:03AM  Corporate Profits' New Enemy Is the 'Dollar Vortex' Investopedia
Feb-04-19 10:32PM  J&J, plaintiffs 'close' to deal on Pinnacle hip implant lawsuits: lawyer Reuters
07:33PM  J&J, plaintiffs 'close' to deal on Pinnacle hip implant lawsuits - lawyer Reuters
05:38PM  U.S. Senate panel invites seven drug companies to testify on drug costs Reuters
01:58PM  Celgene Highlights What Bristol-Myers Squibb Is Getting Motley Fool
08:23AM  Better Buy: Johnson & Johnson vs. Merck & Co. Motley Fool
02:00AM  Johnson & Johnson Vision Announces Availability in Europe of TECNIS Eyhance IOL, a Next-Generation Monofocal Intraocular Lens for Patients with Cataracts PR Newswire
Feb-03-19 09:01AM  A War on High Drug Prices Could Boost Biosimilars Motley Fool
Feb-02-19 07:33AM  Better Buy: Johnson & Johnson vs. AbbVie Motley Fool
Feb-01-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Johnson & Johnson - JNJ Business Wire
08:01PM  It's Official: Trump Proposes Plan to Stop Skyrocketing Drug Prices Motley Fool
09:49AM  Merck (MRK) Beats on Q4 Earnings & Sales as Keytruda Shines Zacks
08:15AM  Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY Zacks
Jan-31-19 10:32PM  Missouri Supreme Court suspends second talc cancer trial in weeks Reuters
07:23PM  J&J's Erleada Meets Both Primary Endpoints in Late-Stage Study Zacks
03:02PM  9 Best Dividend Stocks to Buy for Every Investor InvestorPlace
03:49AM  Exclusive: Sri Lanka halts imports of Johnson & Johnson Baby Powder pending asbestos tests Reuters
02:11AM  Exclusive: Sri Lanka halts imports of Johnson & Johnson Baby Powder pending asbestos tests Reuters
Jan-30-19 08:06PM  The Value of Patience: Cramer's 'Mad Money' Recap (Wednesday 1/30/19) TheStreet.com
04:47PM  Roche Halts Two Late-Stage Studies on Alzheimer's Candidate Zacks
03:08PM  Yacktman Fund's 4th Quarter Shareholder Commentary GuruFocus.com
08:16AM  3 Big Pharmas Expecting a Softer 2019 Motley Fool
Jan-29-19 09:34PM  Better Buy: Johnson & Johnson vs. Pfizer Motley Fool
02:22PM  U.S. senator asks J&J for documents on talc, baby powder safety Reuters
01:18PM  U.S. senator asks J&J for documents on talc, baby powder safety Reuters
12:29PM  Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
10:32AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Boeing, Starbucks, Norfolk and Prologis Zacks
09:41AM  Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips Zacks
09:15AM  AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting Zacks
06:06AM  3 Stocks Warren Buffett Might Sell Next Motley Fool
Jan-28-19 05:45PM  Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know Zacks
03:26PM  MiRus CEO Jay Yadav: We cant eliminate risk completely (Video) American City Business Journals
02:24PM  Top Research Reports for Johnson & Johnson, Boeing & Starbucks Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM